← Back to Clinical Trials
Recruiting NCT03664609

NCT03664609 Deep Brain Stimulation (DBS) Retrospective Outcomes Study

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT03664609
Status Recruiting
Phase —
Sponsor Boston Scientific Corporation
Condition Parkinson Disease
Study Type OBSERVATIONAL
Enrollment 5,000 participants
Start Date 2019-03-12
Primary Completion 2028-12

Trial Parameters

Condition Parkinson Disease
Sponsor Boston Scientific Corporation
Study Type OBSERVATIONAL
Phase N/A
Enrollment 5,000
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2019-03-12
Completion 2028-12
Interventions
Deep Brain Stimulation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The primary objective of this study is to characterize real-world clinical outcomes of Deep Brain Stimulation (DBS) using retrospective review of de-identified patient records.

Eligibility Criteria

Inclusion Criteria: * Must be previously treated with or eligible for implantation with a deep brain stimulation system Exclusion Criteria: * No Exclusion Criteria

Related Trials

Related Intelligence Guides

In-depth guides covering this condition's trials, eligibility, and what to expect.

VIEW ON CLINICALTRIALS.GOV ↗ MORE PARKINSON DISEASE TRIALS
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology